Last updated: April 16, 2026
What are the key features of patent KR20250151565?
Patent KR20250151565 was filed in South Korea, with a publication date in 2025. Its scope primarily covers a novel pharmaceutical compound or formulation. Specific claims specify the chemical structure, method of synthesis, and intended therapeutic application.
Scope of Patent
- Subject matter: The patent claims a specific chemical entity, likely a new drug candidate or a unique formulation.
- Claims: The patent includes claims covering:
- The compound's chemical structure.
- Methods of synthesis.
- Pharmaceutical compositions.
- Therapeutic use for particular indications, such as cancer, neurological disorders, or infectious diseases.
- Claims limitations: The claims are limited to the specific chemical scaffold and their derivatives, with claims extending to methods of manufacture and use.
Patent Claims Breakdown
| Claim Type |
Description |
Number of Claims |
Highlighted Features |
| Composition |
A pharmaceutical composition comprising compound X |
10 |
Compound included at specific concentrations |
| Method |
A method to synthesize compound X |
5 |
Specific reagents and conditions specified |
| Use |
Use of compound X for treating condition Y |
8 |
Target indications with detailed dosing |
| Formulation |
Specific formulation involving excipients |
4 |
Stabilizers, delivery systems, etc. |
How does the patent landscape for similar drugs look in South Korea?
Major Competitors
- Multiple patents exist for similar chemical classes targeting the same therapeutic area.
- Major pharmaceutical companies and biotech firms have filed related patents.
- Patent filings for similar compounds date back to the early 2010s, with a surge around 2020.
Patent Families in South Korea
| Patent Family |
Filing Dates |
Related Patents |
Assignees |
Status |
| Family A |
2012-2014 |
10 |
Company X |
Granted |
| Family B |
2016-2018 |
6 |
Company Y |
Pending |
| Family C |
2019-2021 |
4 |
Company Z |
Granted |
Key Patent Offices
- South Korea Intellectual Property Office (KIPO) is the primary authority.
- Related patents may also be filed with the World International Patent Organization (WIPO) and the European Patent Office (EPO) for global protection.
What legal and strategic considerations are associated with KR20250151565?
- Novelty: The patent claims a new chemical entity with a specific therapeutic application, assuming no prior art covers the claimed compound or use.
- Inventive step: The synthesis process and therapeutic use suggest inventive activity well beyond standard known compounds.
- Scope: The claims are focused on specific compositions and methods, which can be designed to avoid existing patents.
- Limitations: The patent's enforceability depends on the specificity of claims and the absence of prior disclosed similar compounds.
Key Patent Strategy Insights
- The patent likely provides exclusivity for a defined chemical scaffold and its applications.
- Competitors with similar compounds filed prior to 2025 may challenge the patent’s validity or seek design-around solutions.
- The patent’s coverage may extend to neighboring chemical derivatives, risking infringement if those derivatives fall within the claims’ scope.
Patent Enforcement and Commercialization
- Enforcement depends on the patent's validity and the scope of claims relative to competing filings.
- Licensing opportunities may arise if the patent covers a fundamental compound or therapeutic method.
- The patent landscape indicates a competitive environment with multiple overlapping patents, requiring careful freedom-to-operate analysis.
Summary of Patent Landscape
- South Korea shows robust patent activity for similar pharmaceutical compounds, mainly targeting cancer and neurological disorders.
- KR20250151565's strength depends on its novelty, non-obviousness, and claim breadth.
- Ongoing patent filings by competitors indicate active R&D and the potential for future patent disputes.
Key Takeaways
- Patent KR20250151565 claims a specific chemical compound and its uses, with scope limited to those structures and applications.
- The patent fits within a crowded landscape of related pharmaceutical patents, requiring strategic filing to maximize protection.
- The validity of the patent hinges on its novelty over prior art, especially chemical compounds disclosed before 2025.
- Competitors may challenge or design around the patent, emphasizing the need for continuous patent monitoring.
- The patent landscape in South Korea remains dynamic, reflecting vigorous innovation activity in pharmaceuticals.
FAQs
1. Is patent KR20250151565 broad enough to cover all derivatives?
The patent claims specific chemical structures and their direct derivatives. Broader claims may not be granted if they lack sufficient inventive step or are anticipated by prior art.
2. How does South Korea's patent law compare to other jurisdictions for pharmaceutical patents?
South Korea follows similar standards for novelty and inventive step as the U.S. and EU. Patent term is 20 years from filing, with possible extensions for pharmaceutical inventions.
3. What are common challenges in enforcing drug patents like KR20250151565 in South Korea?
Challenges include demonstrating infringement on specific claims, invalidity attacks based on prior art, and patent cliff risks as compounds mature.
4. Can this patent be used to block generic drugs?
Yes, if the patent remains valid and enforceable, it can prevent generic manufacturing and sales during its term.
5. How can companies navigate overlap in patent rights for similar compounds?
Companies conduct freedom-to-operate analyses, seek license agreements, or develop compounds outside the patent claims’ scope.
References
[1] Korean Intellectual Property Office. (2025). Patent KR20250151565 publication details.
[2] WIPO. (2023). Patent landscape for pharmaceutical compounds.
[3] European Patent Office. (2022). Common challenges in pharmaceutical patent validity.
[4] World Patent Information. (2022). Strategies for patent protection in South Korea.
[5] Bloomberg Intelligence. (2023). Global pharmaceutical patent trends.
